Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GCSH pseudogene 4 (GCSHP4) is one of several pseudogenes related to the glycine cleavage system protein H (GCSH). The canonical GCSH gene encodes a mitochondrial protein involved in glycine degradation as part of the glycine cleavage system, with known roles in rare metabolic diseases such as nonketotic hyperglycinemia[2][5]. Pseudogenes such as GCSHP4 are typically non-protein-coding and lack demonstrated biological function or known disease associations. There is no evidence that GCSHP4 encodes a receptor, enzyme, or constitutes a therapeutic target, and it is not referenced in curated resources describing molecular targets. Its mention is mostly in the context of non-functional pseudogenes distributed throughout the genome in relation to the GCSH gene[2][5]. While some pseudogenes can exert biological effects via RNA or gene regulation[6], there is no published data implicating GCSH pseudogene 4 in such processes. The abbreviation "GCSHP4" is uniquely derived and may reflect a database or annotation artifact, with no established aliases or target roles. If this target is intended to reflect a functional gene or protein, its designation is incorrect and incomplete.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GCSH pseudogene 4 (GCSHP4).